Review article: immunogenicity of anti‐TNF biologics in IBD – the role of patient, product and prescriber factors

E-ISSN： 1365-2036|38|10|1188-1197

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.10, 2013-11, pp. : 1188-1197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: applying pharmacokinetics to optimise dosing of anti‐TNF biologics in acute severe ulcerative colitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1094-1103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: dermatological complications of immunosuppressive and anti‐TNF therapy in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1002-1024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 391-405

John Wiley & Sons Inc

Access to resources Recommend Favorite